Company Overview
Snapshot
Founded in July 2020 by Vitali Binyaminov, MedicannX operates with 1–10 employees. The company has raised $18.95M across one funding round from Darwin Real Estate and Investments. In July 2024, MedicannX secured significant funding to advance its medical cannabis cultivation and product development.
Business overview
MedicannX is a medical cannabis company specializing in a unique aeroponic cultivation technology. The company develops medical products using an automated, oxygen-based aeroponic system housed in climate-controlled growing rooms. This technology allows for precise monitoring and cultivation independent of external weather conditions, serving the Health Tech & Life Sciences sector, particularly within the Pharma & Medical Biotechnology and Medical Cannabis industries.
Strategic signal
In July 2024, MedicannX announced a significant funding round, raising NIS 70 million (approximately $18.95 million). This capital infusion is a strong validation of the company's innovative aeroponic cultivation method for medical cannabis and signals investor confidence in its potential to develop advanced medical products within the Health Tech & Life Sciences sector.
Log in to access full profile ›Company Intelligence Q&A
- When was MedicannX founded?
- MedicannX was founded in July 2020.
- Who is the founder of MedicannX?
- Vitali Binyaminov is the Founder & CEO of MedicannX.
- What is MedicannX's primary technology?
- MedicannX utilizes an aeroponic cultivation method based on oxygen use for growing cannabis. This automated system operates in climate-controlled rooms, enabling precise monitoring and cultivation.
- How much capital has MedicannX raised?
- MedicannX has raised a total of $18.95M.
- What was a key funding event for MedicannX?
- In July 2024, MedicannX raised NIS 70 million (approximately $18.95 million) in a funding round, with Darwin Real Estate and Investments participating.